Heron Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €247.12M +14.8% €67.03M +9.8% 27.1% -0.012 pp N/A N/A
    (estimated) €215.33M +19.0% €61.06M +78.8% 28.4% +0.095 pp N/A N/A
    (estimated) €180.93M +18.8% €34.14M +258.0% 18.9% +0.13 pp N/A N/A
    (estimated) €152.32M +13.0% €9.54M -362.9% 6.3% +0.090 pp N/A N/A
    (estimated) €134.82M +8.5% -€3.63M -69.0% -2.7% +0.067 pp N/A N/A
    €124.31M -24.9% -€11.70M -87.7% -9.4% +0.48 pp -€17.94M -63.6% -14.4% +0.15 pp
    €165.55M +78.5% -€95.25M -17.8% -57.5% +0.67 pp -€49.32M -60.5% -29.8% +1.0 pp
    €92.76M +24.7% -€115.89M -38.2% -124.9% +1.3 pp -€125.00M -27.6% -134.7% +0.97 pp
    €74.39M -2.6% -€187.53M -3.0% -252.1% +0.011 pp -€172.60M +12.5% -232.0% -0.31 pp
    €76.37M -39.3% -€193.36M +9.6% -253.2% -1.1 pp -€153.36M +51.6% -200.8% -1.2 pp
    €125.76M +88.4% -€176.40M +14.5% -140.3% +0.91 pp -€101.17M -35.7% -80.4% +1.6 pp
    €66.75M +151.8% -€154.08M -9.4% -230.8% +4.1 pp -€157.35M +8.9% -235.7% +3.1 pp
    €26.51M +2,305.6% -€170.14M +14.1% -641.9% +130 pp -€144.52M +28.1% -545.2% +97 pp
    €1.10M +∞% -€149.17M +77.4% -13,537.4% -140 pp -€112.83M +69.1% -10,239.4% -100 pp
    €0.00 +NaN% -€84.08M +27.8% N/A -€66.72M +31.6% N/A
    €0.00 +NaN% -€65.79M +38.1% N/A -€50.70M +50.6% N/A
    €0.00 -100.0% -€47.63M +136.8% N/A -€33.67M +143.7% N/A
    €556.56K +0.0% -€20.12M +97.6% -3,614.2% -18 pp -€13.82M +122.5% -2,482.5% -14 pp
    €556.56K -50.3% -€10.18M +60.8% -1,828.8% -13 pp -€6.21M +33.4% -1,115.8% -7.0 pp
    €1.12M +3.2% -€6.33M -26.7% -564.6% +2.3 pp -€4.66M -50.9% -415.4% +4.6 pp
    €1.09M +241.7% -€8.64M -56.6% -795.2% +55 pp -€9.47M -54.1% -872.1% +56 pp
    €317.91K -10.4% -€19.92M +14.7% -6,266.9% -14 pp -€20.66M +42.7% -6,497.8% -24 pp
    €354.96K -92.4% -€17.37M -482.9% -4,893.9% -50 pp -€14.47M -279.3% -4,077.7% -43 pp
    €4.64M +0.0% €4.54M -164.1% 97.7% +2.5 pp €8.07M -229.9% 173.8% +3.1 pp
    €4.64M -0.2% -€7.07M -11.0% -152.3% +0.18 pp -€6.21M -4.5% -133.8% +0.060 pp
    €4.66M +11.5% -€7.94M +111.3% -170.6% -0.81 pp -€6.50M +20.3% -139.7% -0.10 pp
    €4.18M -16.6% -€3.76M +15.5% -90.0% -0.25 pp -€5.41M +33.5% -129.4% -0.49 pp
    €5.01M +32.6% -€3.25M +50.3% -65.0% -0.077 pp -€4.05M -24.4% -80.8% +0.61 pp
    €3.78M +30.3% -€2.17M -129.4% -57.3% -3.1 pp -€5.35M +111.6% -141.7% -0.54 pp
    €2.90M -83.5% €7.37M -507.2% 254.1% +2.6 pp -€2.53M +879.0% -87.3% -0.86 pp
    €17.58M +2.0% -€1.81M -22.2% -10.3% +0.032 pp -€258.46K -125.0% -1.5% -0.075 pp
    €17.23M +16.3% -€2.33M +50.0% -13.5% -0.030 pp €1.03M -53.8% 6.0% -0.091 pp
    €14.82M -8.0% -€1.55M -80.9% -10.5% +0.40 pp €2.24M -148.1% 15.1% +0.44 pp
    €16.11M +16.1% -€8.10M +0.0% -50.3% +0.081 pp -€4.65M -28.9% -28.9% +0.18 pp
    €13.87M +1.3% -€8.10M -4.1% -58.4% +0.033 pp -€6.55M -5.0% -47.2% +0.031 pp
    €13.70M -20.1% -€8.44M -1.0% -61.6% -0.12 pp -€6.89M -23.8% -50.3% +0.024 pp
    €17.14M +172.6% -€8.53M +76.8% -49.7% +0.27 pp -€9.05M +600.0% -52.8% -0.32 pp
    €6.29M +160.7% -€4.82M +30.2% -76.7% +0.77 pp -€1.29M -59.5% -20.5% +1.1 pp
    €2.41M +16.7% -€3.70M +10.3% -153.6% +0.089 pp -€3.19M +15.6% -132.1% +0.012 pp
    €2.07M -14.3% -€3.36M -13.3% -162.5% -0.018 pp -€2.76M +3.2% -133.3% -0.23 pp
    €2.41M -€3.88M -160.7% -€2.67M -110.7%

    Notifications